| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | -0.39 | 0.01 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.42 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |